Abstract
The pseudotumor cerebri, a neurological syndrome clinically characterized by headaches, vomiting and bilateral papilledema, occurred in two patients, previously subjected to total thyroidectomy for differentiated thyroid carcinoma, after initiation of levothyroxine replacement therapy. In patients with thyroid cancer, subjected to thyroidectomy and then thyroid hormone replacement therapy, the possible development of pseudotumor cerebri syndrome should be considered and differentiated from CNS symptoms due to brain metastases.
Similar content being viewed by others
References
Sugar O Central neurological complications of hypoparathyroidism. Arch. Neurol. Psychiatry 70: 86, 1953.
Dees S.C., McKay H.W. Jr. Occurrence of pseudotumor cerebri (benign intracranial hypertension) during treatment of children with asthma by adrenal steroids: report of three cases. Pediatrics 23: 1143, 1959.
Walker A.E., Adamkiewicz J.J. Pseudotumor cerebri associated with prolonged corticosteroid therapy: reports of four cases. JAMA 188: 779, 1964.
Neville B.G.R., Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br. Med. J. 3: 554, 1970.
Van Wyck J.J., Grumbach M.M. Syndrome of precocious menstruation in juvenile hypothyroidism: an example of hormonal overlap in pituitary feed-back. J. Pediatr. 57: 416, 1960.
Van Dop C., Conte F.A., Koch T.K., Clark S.J., Wilson-Davis S.L., Grumbach M.M. Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism. N. Engl. J. Med. 308: 1076, 1983.
Prendes J.L., McLean W.T. Jr. Pseudotumor cerebri during treatment for hypothyroidism. South Med. J. 71: 977, 1978.
Panza N., De Rosa M., Lombardi G., Salvatore M. Serum thyroglobulin in patients with early thyroid cancer who have residual thyroid tissue after total thyroidectomy. Lancet 1: 398, 1984.
Schlumberger M., Fragu P., Parmentier C., Tubiana M. Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue. Acta Endocrinol. (Kbh.) 98: 215, 1981.
Panza N., Lombardi G., Minozzi M., Salvatore M., Claudio F., Mariano A., Macchia V. [131]-total body scan and serum thyroglobulin assay in the follow-up of surgically treated patients affected by differentiated thyroid carcinoma. J. Nucl. Med. All. Sci. 28: 9, 1984.
Van Herle A.J., Viller R.P. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinoma. J.Clin. Invest. 56: 272, 1975.
Pacini F., Pinchera A., Grassi C., Grasso L., Doveri F., Baschieri L. Serum thyroglobulin in thyroid carcinoma and other thyroid disorders. J. Endocrinol. Invest. 3: 283, 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Panza, N., De Rosa, M., Lombardi, G. et al. Pseudotumor cerebri and thyroid-replacement therapy in patients affected by differentiated thyroid carcinoma. J Endocrinol Invest 8, 357–358 (1985). https://doi.org/10.1007/BF03348513
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348513